Literature DB >> 22175901

Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis.

Simona Zanotti1, Sara Gibertini, Claudia Di Blasi, Cristina Cappelletti, Pia Bernasconi, Renato Mantegazza, Lucia Morandi, Marina Mora.   

Abstract

AIMS: To increase our understanding of profibrotic mechanisms in dystrophic muscle. METHODS AND
RESULTS: Extracellular matrix, fibrosis-related molecules and histopathology were assessed in skeletal muscle of patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and congenital muscular dystrophy type 1A (MDC1A).Osteopontin expression was much higher in DMD and MDC1A than in BMD and control muscle. Osteopontin was expressed in mononuclear cell infiltrates, on some muscle fibre surfaces, in regenerating fibres, and in calcified fibres. In all pathological muscles, matrix metalloproteinase (MMP)-1 was increased around groups of fibres that were also characterized by absence of collagen 1. The amounts of MMP-2, MMP-9 and tissue inhibitor of MMP -1 transcripts were also increased, whereas their proteins were variably expressed in muscle fibres (surface or cytoplasm) and at foci of necrosis and regeneration. Inflammatory cells, fibroblasts and myofibroblasts were more numerous in DMD and MDC1A than in BMD muscle.
CONCLUSIONS: Several fibrosis-related factors are greatly altered in severely dystrophic skeletal muscle. Osteopontin was the most conspicuously upregulated, both as transcript and as protein, in muscle fibres and infiltrating cells, indicating an intimate involvement in fibrosis, and also in inflammation and muscle regeneration, although its precise roles in these processes remain to be elucidated.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175901     DOI: 10.1111/j.1365-2559.2011.04051.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 2.  Outside in: The matrix as a modifier of muscular dystrophy.

Authors:  Mattia Quattrocelli; Melissa J Spencer; Elizabeth M McNally
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-12-21       Impact factor: 4.739

3.  Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.

Authors:  Tony Huynh; Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Christopher R Heier; Jack H Van Der Meulen; Qing Yu; Mark Harris; Christopher J Nolan; Guy Haegeman; Miranda D Grounds; Kanneboyina Nagaraju
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

4.  Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle.

Authors:  Charles N Pagel; Dimuthu K Wasgewatte Wijesinghe; Neda Taghavi Esfandouni; Eleanor J Mackie
Journal:  J Cell Commun Signal       Date:  2013-12-08       Impact factor: 5.782

Review 5.  Immune-mediated pathology in Duchenne muscular dystrophy.

Authors:  Amy S Rosenberg; Montserrat Puig; Kanneboyina Nagaraju; Eric P Hoffman; S Armando Villalta; V Ashutosh Rao; Lalage M Wakefield; Janet Woodcock
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

6.  Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice.

Authors:  Michael G Poulos; Ranjan Batra; Moyi Li; Yuan Yuan; Chaolin Zhang; Robert B Darnell; Maurice S Swanson
Journal:  Hum Mol Genet       Date:  2013-05-08       Impact factor: 6.150

7.  Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.

Authors:  Maria Laura Jorge Micheletto; Tulio de Almeida Hermes; Bruno Machado Bertassoli; Giuliana Petri; Matheus Moreira Perez; Fernando Luiz Affonso Fonseca; Alzira Alves de Siqueira Carvalho; David Feder
Journal:  Int J Exp Pathol       Date:  2020-12-09       Impact factor: 1.925

8.  Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog.

Authors:  Akinori Nakamura; Masanori Kobayashi; Mutsuki Kuraoka; Katsutoshi Yuasa; Naoko Yugeta; Takashi Okada; Shin'ichi Takeda
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Authors:  Fernanda Pinto-Mariz; Luciana Rodrigues Carvalho; Alexandra Prufer De Queiroz Campos Araujo; Wallace De Mello; Márcia Gonçalves Ribeiro; Maria Do Carmo Soares Alves Cunha; Pedro Hernan Cabello; Ingo Riederer; Elisa Negroni; Isabelle Desguerre; Mariana Veras; Erica Yada; Yves Allenbach; Olivier Benveniste; Thomas Voit; Vincent Mouly; Suse Dayse Silva-Barbosa; Gillian Butler-Browne; Wilson Savino
Journal:  Skelet Muscle       Date:  2015-12-10       Impact factor: 4.912

Review 10.  Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

Authors:  Florian Kahles; Hannes M Findeisen; Dennis Bruemmer
Journal:  Mol Metab       Date:  2014-03-22       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.